Characteristics | Cholecystitis group (n = 160) | Control group (n = 60) | P |
---|---|---|---|
Age, year (mean, SD) | 69.14 ± 6.13 | 69.20 ± 6.36 | 0.952 |
Gender, n (%) | Â | Â | Â |
Male | 70(44) | 29(48) | Â |
Female | 90(56) | 31(52) | 0.547 |
BMI, kg/m2 (mean, SD) | 23.13 ± 1.61 | 23.18 ± 1.74 | 0.3664 |
Comorbidities, n (%) | Â | Â | Â |
Hypertension, n (%) | 53(32.5) | 7(11.7) | 0.0015 |
Diabetes, n (%) | 69(43.1) | 5(8.3) | < 0.001 |
TIA/stroke, n (%) | 4(2.5) | 1(1.6) | 0.7119 |
Angina, n (%) | 8(5.0) | 0(0) | 1 |
Arrhythmia, n (%) | 7(4.3) | 2(3.3) | 0.7283 |
Heart failure, n (%) | 3(1.8) | 0(0) | 1 |
Laboratory results | Â | Â | Â |
Hemoglobin, g/L (mean, SD) | 136.1 ± 15.48 | 133.6 ± 10.2 | 0.406 |
CRP, mg/L (mean, SD) | 92.7 ± 65.1 | 4.4 ± 3.3 | < 0.001 |
WCC, ×109/L (mean, SD) | 15.2 ± 8.62 | 8.3 ± 2.98 | < 0.001 |
Neutrophils, ×109/L (mean, SD) | 6.17 ± 2.28 | 2.57 ± 0.81 | < 0.001 |
Lymphocyte, ×109/L (mean, SD) | 1.12 ± 0.39 | 1.45 ± 0.15 | < 0.001 |
NLR (mean, SD) | 7.36 ± 3.73 | 1.78 ± 0.60 | < 0.001 |
Total bilirubin, mmol/L (mean, SD) | 17 ± 5.40 | 12 ± 4.39 | < 0.001 |
GGT, U/L (mean, SD) | 53 ± 12.76 | 61 ± 8.75 | 0.692 |
ALP, U/L (mean, SD) | 92 ± 21.73 | 79 ± 44.93 | 0.274 |
AST, U/L (mean, SD) | 28 ± 10.14 | 27 ± 9.08 | 0.619 |
Amylase, U/L (mean, SD) | 41 ± 14.13 | 66 ± 37.12 | < 0.001 |
ALT, U/L (mean, SD) | 29 ± 7.29 | 38 ± 6.76 | 0.574 |